Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 865 | 3,484 | 11,427 | 27,266 | 17,640 |
| Receivables | N/A | N/A | N/A | 7 | N/A |
| TOTAL | $1,473 | $3,866 | $14,290 | $27,707 | $17,983 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 121 | 46 | 43 |
| Other Non-Current Assets | 0 | 1,101 | 347 | 478 | 655 |
| TOTAL | $N/A | $1,101 | $469 | $524 | $698 |
| Total Assets | $1,473 | $4,966 | $14,758 | $28,231 | $18,681 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,356 | 1,476 | 1,124 | 948 | 937 |
| TOTAL | $1,684 | $1,798 | $1,596 | $1,445 | $1,342 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 152 | 300 | 494 |
| TOTAL | $N/A | $N/A | $152 | $300 | $494 |
| Total Liabilities | $1,684 | $1,798 | $1,749 | $1,745 | $1,836 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 715 | 149 | 67 | 65 | 61 |
| Common Shares | 13 | 3 | 2 | 2 | 92 |
| Retained earnings | -216,786 | -206,218 | -185,563 | -171,274 | -154,445 |
| TOTAL | $-212 | $3,168 | $13,009 | $26,486 | $16,845 |
| Total Liabilities And Equity | $1,473 | $4,966 | $14,758 | $28,231 | $18,681 |